Stockscreener 앱 받기
393.21
0.33%
-1.32
시간 외 거래:
393.21
전일 마감가:
$394.53
열려 있는:
$393
하루 거래량:
1.40M
Relative Volume:
0.87
시가총액:
$100.82B
수익:
$11.39B
순이익/손실:
$3.64B
주가수익비율:
28.11
EPS:
13.99
순현금흐름:
$3.50B
1주 성능:
-0.52%
1개월 성능:
+0.11%
6개월 성능:
-22.10%
1년 성능:
-18.99%
1일 변동 폭
$391.93
$398.29
1주일 범위
$387.19
$398.50
52주 변동 폭
$362.50
$519.88
버텍스 파마슈티컬 Stock (VRTX) Company Profile
명칭
Vertex Pharmaceuticals Inc
전화
(617) 341-6393
주소
50 NORTHERN AVENUE, BOSTON, MA
VRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
버텍스 파마슈티컬 Stock (VRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Raymond James | Mkt Perform |
| 2025-08-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-05-07 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-02-12 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2025-02-11 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2025-01-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-19 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-14 | 개시 | Citigroup | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Perform |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-08-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-06-27 | 개시 | Redburn Atlantic | Buy |
| 2024-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-02-06 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-02-02 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-01-31 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2024-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2024-01-24 | 다운그레이드 | Canaccord Genuity | Hold → Sell |
| 2023-12-14 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2023-05-30 | 개시 | William Blair | Outperform |
| 2023-05-04 | 재개 | Piper Sandler | Overweight |
| 2023-03-21 | 개시 | Bernstein | Outperform |
| 2023-01-18 | 개시 | Canaccord Genuity | Hold |
| 2023-01-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-12-19 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-01 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-05-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-03 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-02-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-01-27 | 재확인 | JP Morgan | Overweight |
| 2022-01-27 | 재확인 | Morgan Stanley | Underweight |
| 2022-01-27 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-01-27 | 재확인 | Stifel | Hold |
| 2022-01-27 | 재확인 | Wolfe Research | Outperform |
| 2022-01-20 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-09-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-07-20 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2021-07-19 | 재개 | Wolfe Research | Outperform |
| 2021-07-01 | 개시 | Raymond James | Mkt Perform |
| 2021-06-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-02-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-30 | 개시 | Daiwa Securities | Outperform |
| 2020-11-30 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-20 | 개시 | Bernstein | Outperform |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-07-31 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-28 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-11-19 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-10-17 | 재개 | BofA/Merrill | Buy |
| 2019-09-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-08-01 | 다운그레이드 | Needham | Buy → Hold |
| 2019-05-23 | 재개 | Citigroup | Buy |
| 2019-05-21 | 개시 | Credit Suisse | Outperform |
| 2019-04-12 | 개시 | Evercore ISI | In-line |
| 2019-03-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2019-03-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-02-06 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
버텍스 파마슈티컬 주식(VRTX)의 최신 뉴스
Fortis Capital Advisors LLC Makes New $850,000 Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Plato Investment Management Ltd Sells 820 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Ilmarinen Mutual Pension Insurance Co Buys 5,000 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
CEO Moves: Is Vertex Pharmaceuticals Incorporated showing insider buyingBreakout Watch & Weekly Top Gainers Trade List - خودرو بانک
1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals - The Globe and Mail
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Cim LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Intech Investment Management LLC - MarketBeat
Advisors Capital Management LLC Trims Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Voleon Capital Management LP Sells 7,475 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Zurich Insurance Group Ltd FI Purchases 158,379 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Integrity Alliance LLC. Makes New $445,000 Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Boosts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Fred Alger Management LLC Has $6.46 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Peloton Wealth Strategists Raises Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
NewEdge Advisors LLC Has $5.31 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Alaethes Wealth LLC Purchases Shares of 3,051 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
9,601 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by AG2R LA Mondiale Gestion D Actifs - MarketBeat
Voya Investment Management LLC Acquires 128,432 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Swedbank AB Decreases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Strs Ohio Invests $37.74 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by McAdam LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Coppell Advisory Solutions LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Woodline Partners LP - MarketBeat
Ascent Group LLC Trims Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Evercore ISI Cuts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $475.00 - MarketBeat
Vertex Pharmaceuticals: Buying The CF Fortress For The JOURNAVX Optionality (NASDAQ:VRTX) - Seeking Alpha
Focus Partners Wealth Has $69.43 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Belpointe Asset Management LLC Has $1.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Gotham Asset Management LLC Cuts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Curi RMB Capital LLC Has $204,000 Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Sepio Capital LP Purchases 1,311 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
ToolGen and BarentsKrans step up CRISPR battle against Vertex - JUVE Patent
Jacobs Levy Equity Management Inc. Buys Shares of 66,234 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AQR Capital Management LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis - Business Wire
Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating - MarketScreener
Polar Asset Management Partners Inc. Cuts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
버텍스 파마슈티컬 (VRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.02%
2.25%
자본화:
|
볼륨(24시간):